comparemela.com

Latest Breaking News On - Aytu biopharma daily - Page 1 : comparemela.com

Aytu BioPharma, Inc. (NASDAQ:AYTU) Sees Large Growth in Short Interest

Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 419,400 shares, an increase of 9.5% from the April 30th total of 383,000 shares. Based on an average daily volume of 19,300 shares, the days-to-cover ratio […]

United-states
Aytu-biopharma
Aytu-biopharma-inc
Consumer-health
Aytu-biopharma-company-profile
Nasdaq
Get-free-report
Aytu-biopharma-daily

Aytu BioPharma, Inc. (NASDAQ:AYTU) Sees Significant Growth in Short Interest

Aytu BioPharma, Inc. (NASDAQ:AYTU) Sees Significant Growth in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Aytu-biopharma
Consumer-health
Nasdaq
Aytu-biopharma-inc
Get-free-report
Aytu-biopharma-daily

Aytu BioPharma (NASDAQ:AYTU) Trading 1.4% Higher

Aytu BioPharma (NASDAQ:AYTU) Trading 1.4% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Aytu-biopharma
Nasdaq
Aytu-biopharma-inc
Consumer-health
Get-free-report
Aytu-biopharma-daily

Aytu BioPharma (NASDAQ:AYTU) Trading Up 1.4%

Aytu BioPharma (NASDAQ:AYTU) Trading Up 1.4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Aytu-biopharma
Nasdaq
Aytu-biopharma-inc
Consumer-health
Get-free-report
Aytu-biopharma-daily

Aytu BioPharma (AYTU) Set to Announce Earnings on Wednesday

Aytu BioPharma (NASDAQ:AYTU – Get Free Report) is scheduled to release its earnings data on Wednesday, February 14th. Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last issued its quarterly earnings results on Tuesday, November 14th. The company reported ($1.48) earnings per share (EPS) for the quarter. The firm had revenue of $22.10 million for the […]

United-states
Aytu-biopharma
Millennium-management
Dimensional-fund-advisors
Renaissance-technologies
Prudential-financial-inc
Aytu-biopharma-inc
Consumer-health
Commonwealth-equity-services
Get-free-report
Equity-services
Fund-advisors

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.